PCFCL represents about 55% to 60% of primary cutaneous B-cell lymphomas, a heterogeneous group of diseases with unknown causes.
PCFCL represents about 55% to 60% of primary cutaneous B-cell lymphomas, a heterogeneous group of diseases with unknown causes.